EPCAM and intrahepatic cholangiocarcinoma: Amongst the non-immune TME (CD45-/EpCAM-), cluster 22 (endothelial cells) was increased in ICC/IDC-enriched tumors compared to benign-enriched prostate (Fig. 2d).